Neuronetics (STIM) Cash from Financing Activities (2017 - 2026)
Neuronetics (STIM) reported Cash from Financing Activities of -$5.6 million for Q1 2026, down 129.39% year-over-year from $19.0 million in Q1 2025, and down 441.98% quarter-over-quarter from -$1.0 million in Q4 2025.
Neuronetics (STIM) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Cash from Financing Activities data on file, last reported at -$5.6 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$5.6 million, down 129.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (down 77.76% YoY), and the FY2025 annual result was $35.8 million, up 626.59% from the prior year.
- Cash from Financing Activities slipped to -$5.6 million in Q1 2026 per STIM's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $22.3 million in Q4 2023 and troughed at -$5.6 million in Q1 2026.
- A 5-year average of $5.2 million and a median of $127500.0 in 2022 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 8985.71% in 2023 and fell as far as 720.0% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at $245000.0 in 2022, then soared by 8985.71% to $22.3 million in 2023, then plunged by 57.04% to $9.6 million in 2024, then slumped by 110.76% to -$1.0 million in 2025, then slumped by 441.98% to -$5.6 million in 2026.
- Business Quant data shows STIM's Cash from Financing Activities at -$5.6 million in Q1 2026, -$1.0 million in Q4 2025, and $17.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | -5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 18.98 Mn |
| Mar 31, 2025 | 18.98 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2023 | 22.26 Mn |
| Dec 31, 2023 | 22.26 Mn |
| Jun 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Mar 31, 2023 | 499,000.00 |
| Mar 31, 2023 | 499,000.00 |
| Dec 31, 2022 | 245,000.00 |
| Dec 31, 2022 | 245,000.00 |